Skip to Content
Print Share

MYLAN 2047 MYLAN 2047 (Tacrolimus 5 mg)

Pill with imprint MYLAN 2047 MYLAN 2047 is Gray & Red, Capsule-shape and has been identified as Tacrolimus 5 mg. It is supplied by Mylan Pharmaceuticals Inc..

Tacrolimus is used in the treatment of organ transplant, rejection reversal; organ transplant, rejection prophylaxis and belongs to the drug class calcineurin inhibitors. Risk cannot be ruled out during pregnancy. Tacrolimus 5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for MYLAN 2047 MYLAN 2047

Tacrolimus 5 mg MYLAN 2047 MYLAN 2047
Tacrolimus 5 mg MYLAN 2047 MYLAN 2047

Save up to 80% off prescription medications

Click here for your free Discount Card

Tacrolimus

Imprint
MYLAN 2047 MYLAN 2047
Strength
5 mg
Color
Gray & Red
Size
14.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Calcineurin inhibitors
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Mylan Pharmaceuticals Inc.
Inactive Ingredients
lactose anhydrous, ferrosoferric oxide, silicon dioxide, croscarmellose sodium, gelatin, hypromelloses, lactose monohydrate, magnesium stearate, sodium lauryl sulfate, titanium dioxide, ferric oxide yellow, D&C Red No. 28, D&C Yellow No. 10, D&C Red No. 33, FD&C Blue No. 1, FD&C Blue No. 2, FD&C Red No. 40, propylene glycol, shellac

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC Code Labeler / Repackager
00378-2047 Mylan Pharmaceuticals Inc.
51079-0028 UDL Laboratories Inc.
More Info Imprint Search Print

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer